We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidant Cited for QS Deviations Following FDA Reinspection
Guidant Cited for QS Deviations Following FDA Reinspection
March 2, 2006
The FDA completed a reinspection of Guidant’s St. Paul, Minn., Cardiac Rhythm Management facility, which resulted in a one-item Form 483, the company announced Feb. 23.